Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report

Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report

Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm characterized by CSF3R mutations. Here, we report the first case of a CNL patient positive for a de-novo germline CSF3R T618I variant effectively treated with ruxolitinib and pegylated interferon (peg-IFN), obtaining normaliza...

Full description

Saved in:

Bibliographic Details
Main Authors:	Selene Grano, Valentina Bonuomo, Diana Carli, Veronica Peri, Loredana Farinasso, Ugo Ramenghi, Daniela Cilloni, Carmen Fava
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Hematology
Subjects:	case report chronic neutrophilic leukemia myeloproliferative neoplasm CSF3R mutation NGS
Online Access:	https://www.frontiersin.org/articles/10.3389/frhem.2024.1508463/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
by: Stine Ulrik Mikkelsen, et al.
Published: (2018-08-01)

Dipeptides in CSF and plasma: diagnostic and therapeutic potential in neurological diseases
by: Katharina Küper, et al.
Published: (2024-12-01)

CSF shunts as conduits for metastasis: is there a discrepancy between retrograde and antegrade spread?
by: Andrea Cuschieri, et al.
Published: (2025-02-01)

Colonic growth factors (G-CSF, GM-CSF) and chemokines (MCP-1, MIP-1β) in severe ulcerative colitis
by: Yevgeny A. Konovich, et al.
Published: (2018-08-01)

BOLD-CSF dynamics assessed using real-time phase contrast CSF flow interleaved with cortical BOLD MRI
by: Emiel C. A. Roefs, et al.
Published: (2024-12-01)

Chemokine associations with blood cerebrospinal fluid (CSF) barrier permeability and delirium
by: Paul Denver, et al.
Published: (2025-02-01)

Body position influence on cerebrospinal fluid volume redistribution inside the cranial and spinal CSF compartments
by: I. Strbačko, et al.
Published: (2025-01-01)

Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
by: Iris Wyrobnik, et al.
Published: (2023-12-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Lisa Pieri, et al.
Published: (2010-06-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

CSF Biofire-assisted Rapid Diagnosis of a Case of Cryptococcal Meningoen-cephalitis: A Case Report
by: Ekal Arora, et al.
Published: (2024-11-01)

Role of GM-CSF in normalizing the effect of Uremic Toxins on Neutrophil Apoptosis and Function
by: Nariman Zahran, et al.
Published: (2014-08-01)

The effect of GM-CSF and predictors of treatment outcome in pediatric septic shock patients
by: Zhen-Hao Yu, et al.
Published: (2025-02-01)

Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy
by: Qingchao Shang, et al.
Published: (2025-02-01)

Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver
by: Alessandro Malara, et al.
Published: (2018-11-01)

Immunological Study for Interleukin-5 and GM-CSF for Complications Post-Wisdom Teeth Extraction
by: Susan Hameed Uraibi, et al.
Published: (2024-09-01)

Gait characteristics in idiopathic normal pressure hydrocephalus: a review on the effects of CSF tap test and shunt surgery
by: Iva Hereitová, et al.
Published: (2024-12-01)

Novel rhesus macaque immunoglobulin germline genes identified by three sequencing approaches
by: Yicheng Guo, et al.
Published: (2024-12-01)

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers
by: Xin Wang, et al.
Published: (2025-02-01)

PLEURAL EFFUSION DEVELOPING AS A CONSEQUENCE OF G-CSF ADMINISTRATION IN A PATIENT UNDERGOING AML TREATMENT
by: Ali Turunç, et al.
Published: (2024-12-01)

The effect of a dominant kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy on brain development and neuropathology
by: Jennifer Stables, et al.
Published: (2024-12-01)

A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease
by: Wagner S. Brum, et al.
Published: (2022-01-01)

To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference
by: Nikolayenko-Kamyshova T.P.
Published: (2015-09-01)

CSF3R as a potential prognostic biomarker and immunotherapy target in glioma
by: Minglei Huang, et al.
Published: (2024-06-01)

Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC
by: Kaiting Chen, et al.
Published: (2025-01-01)

The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer
by: Huimin Chen, et al.
Published: (2024-11-01)

Clinical Observation of External Lumbar CSF Drainage Treatment on Intraventricular Hemorrhage
by: Jian LIN, et al.
Published: (2015-10-01)

Discontinuation of Cerebro-Spinal Fluid (CSF) Drainage in Acute Hydrocephalus: A Prospective Cohort Study and Exploratory Data Analysis
by: Anand S. Pandit, et al.
Published: (2024-10-01)

Recapitulation of physiologic and pathophysiologic pulsatile CSF flow in purpose-built high-throughput hydrocephalus bioreactors
by: Ahmad Faryami, et al.
Published: (2024-12-01)

Association of CSF soluble TREM1 levels with hippocampal atrophy in cognitively impaired older adults
by: Hao Shu, et al.
Published: (2025-01-01)

Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial
by: Yinggang Xu, et al.
Published: (2024-11-01)

A synthesized view of the CSF-blood barrier and its surgical implications for aging disorders
by: Birra Taha, et al.
Published: (2025-02-01)

Distribution and clinicopathological characteristics of G-CSF expression in tumor cells and stromal cells in upper tract urothelial carcinoma
by: Go Kobayashi, et al.
Published: (2024-12-01)

Best practices for germline variant and DNA methylation analysis of second- and third-generation sequencing data
by: Ferdinando Bonfiglio, et al.
Published: (2024-11-01)

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer’s disease
by: Georgette Argiris, et al.
Published: (2024-12-01)

Impact of Prophylactic Use of PEG-rhG-CSF on First-Line Immunochemotherapy in Advanced NSCLC: A Cohort Study
by: Li Sun, MD, et al.
Published: (2025-02-01)

cAMP analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in human bone marrow stromal cells in vitro
by: G. Bug, et al.
Published: (1998-01-01)

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria
by: Mohamed A. Yassin, et al.
Published: (2020-07-01)

MPN in the guise of nutritional deficiency
by: Veda P
Published: (2014-08-01)

To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference.
by: T. P. Nikolayenko-Kamyshova
Published: (2015-09-01)